Case 02: Uterocervical cancer
Treatment Performed
“Combined immunotherapy for cancer” was performed for advanced cervical cancer refractory to standard therapies, by combining the cancer vaccine therapy (one course) and a drug to inhibit immunosuppression.
Treatment Outcome
Slight shrinkage of pelvic mass
Before treatment
4 weeks after treatment initiation
7 weeks after treatment initiation
Amelioration of bilateral hydronephrosis
Before treatment
4 weeks after treatment initiation
７ weeks after treatment initiation
The tumor marker decreased
